Memorial Hermann Team A

•Descargar como PPTX, PDF•

2 recomendaciones•2,056 vistas

Carolina Thomas

System Overview Memorial Hermann Healthcare System ,[object Object]

27 Sports Medicine and Rehab CentersTexas Medical Center ,[object Object]

Memorial Hermann – Texas Medical Center,[object Object]

Research best practices and industry trends

Develop program in the same vein as “Art of Heart” campaign,[object Object]

Objective 1: “Hospital Smarts” Customer Touchpoint Survey ,[object Object]

Más contenido relacionado

Similar a Memorial Hermann Team A

Best Practices in Clinical Study Recruitment

CTSI at UCSF

Physician leadership - thoughts from a physician executive

Michael Wagner, MD FACP

Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...

CTSI at UCSF

Tailoring Your Resume For Today’S Pantsuits

Laura Roybal

Quality and cost improvements require the intelligent use of financial and clinical data coupled with education for multi-disciplinary teams who are driving process improvements. Once a data warehouse is established, healthcare organizations need to set up multi-disciplinary clinical, financial, and IT specialist teams to make the best use of the data. Sometimes, financial involvement is minimized or even excluded for a number of reasons that can turn out to be counterproductive. However, including financial measurements and participation up front can help enhance the recognized value and sustainability of quality improvement or waste reduction efforts. the In this session you will learn keys to success and real-life examples of linking clinical, financial and patient satisfaction data via multi-disciplinary teams that produce impressive results.

The Imperative of Linking Clinical and Financial Data to Improve Outcomes - H...

Health Catalyst

Strategic planning model

vkbypo

B. McLaughlin Associates, Inc. (BMA) has been a provider of customized, cost-effective clinical research support for over 18 years. Our services for drug, biologics, and device studies include Study Management, Regulatory and Financial Document Collection and Review, Regulatory Document Audits, Clinical Study Contract/Patient Budget Negotiation, Informed Consent Creation, Review and Change Management, Drug and Biologics Temperature Monitoring (Cold Chain), Data Management, and Clinical Scientist Support. We recognize the importance of a successfully run clinical trial and have the industry experienced staff to enhance your study team and create positive results. Our Study Analysts, Data Analysts, and Study Managers will professionally run your projects to ensure timely completion of all contracted tasks, while keeping quality, accountability, and compliance paramount. Whether your outsourcing requirements are for the full life cycle of a clinical trial or just for a specific need, BMA is here to provide a flexible solution. Our goal is to provide world class support services that keep your projects on time, within budget, and compliant to all regulatory authorities.

BMA Presentation 2011_Handout

BMA

Let 1000 flowers bloom: Support for the current “system”

Cochrane.Collaboration

Towards Value Innovation In Pharma SFE Conference London 062007

A.R.J. (Rob) Halkes

Focus on Fit: A Cultural Blueprint for Successful Physician Recruitment

Jackson Physician Search

Command Leadership

mswtx

Nacubo Heaf Speech On Dashboards

Nick Wallace

NTI2010 Increasing Quality And Safety

Todd_Grivetti

The IFPAC Session: Controlling excipient impact during the product lifecycle. Excipients enable the delivery of actives as a pharmaceutical product. Quality by Design requires that the impact of excipient variability on finished product quality be minimized, or, as paraphrased by Tobyn: - What matters doesn’t vary, and what varies doesn’t matter. This parallels the current practice of categorizing excipients into critical vs non-critical, the assumption being that the latter do not impact the finished product Critical Quality Attributes. This binary classification of criticality has been criticized as too simple and it is not uncommon to observe excursions in finished product quality correlating with variability of a so-called non-critical excipient. The complexity of the excipients, and the products into which they are formulated, contributes to this uncertainty. For excipients, what varies may not have mattered prior to approval, but may come to matter later in the product lifecycle, especially for continuously manufactured products with real time release. Excipients, even if fully compliant and manufactured under GMP, represent a reservoir of special cause variability in finished product quality. By definition this can only be addressed via the Control Strategy. Risk management requires continuous multivariate monitoring of finished product and raw materials to maintain quality and model fidelity.

NIPTE Roadmap 2017 Discussion @ IFPAC 2017

Ajaz Hussain

Ks Manpower Planning

ksways

Understanding Markets, Market Demand, and the Marketing Environment

Sumit Pradhan

Building effective teams - Dr Charles Pain

byersd

3 marketing research

rrhhoohhii

Hst921 Intro 2009 Dec 16

slockemd

Presentation at the Royal Statistical Society's International Conference, Newcastle, September 2013. Paul Askew speakingdata.org.uk paul.askew@speakingdata.org.uk A Framework Understating Statistical Performance This paper presents a framework for understanding, managing and presenting statistical performance data. It provides a manageable, but multidimensional way of organising a range of possible analysis and assessment to provide a rounded and balanced picture for effective understanding and communication. This is founded on a broad scope of assessment, based around three key analytical elements: trend, benchmark and target. That is the first multidimensional perspective. Each of those three key elements are then further disaggregated in a range of appropriate ways to provide a second, more disaggregate, multidimensional analytical assessment. There is then a third more tailored and specific multidimensional disaggregation to provide additional detailed statistical insight. This draws on practical application of this framework in a range of sectors including health, policing and education, and across the public sector spectrum including Central Government, regulation and local service delivery, and in both strategic and operational environments. This provides an overall framework to manage the communication and understanding of statistical performance, and focussed on public data. It provides a framework to build a balanced communication of statistical analysis and messages, and at the same time it provides the user and recipient of statistics and statistical analysis with a framework to both understand and question the scope and content of statistical communication.

A Framework for Statistical Performance

Paul Askew

Similar a Memorial Hermann Team A (20)